Advertisement

Abstract

Papilledema is clinically defined as optic disc swelling resulting only from increased intracranial pressure (ICP), as opposed to the optic disc swelling from other etiologies, such as ischemia or inflammation (Table 3.1). Cerebrospinal fluid pressure (CSF) equal to or greater than 250mmH2O taken in a person lying in the lateral recumbent position is considered abnormally elevated. Normal CSF pressure is usually in the range of 100mmH2O to 250mmH2O.1

Keywords

Optic Disc Intracranial Hypertension Optic Nerve Head Idiopathic Intracranial Hypertension Cerebral Venous Thrombosis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Friedman DI, Jacobson DM. Diagnostic criteria for idiopathic intracranial hypertension. Neurology 2002;59(10):1492–1495.PubMedGoogle Scholar
  2. 2.
    Miller NR. Papilledema. In: Miller NR, Newman NJ, editors. Walsh and Hoyt’s clinical neuroophthalmology: the essentials, 5th ed. Baltimore: Williams & Wilkins; 1998. p. 166–195.Google Scholar
  3. 3.
    Giuseffi V, Wall M, Siegel PZ, Rojas PB. Symptoms and disease associations in idiopathic intracranial hypertension (pseudotumor cerebri): a case-control study. Neurology 1991;41(2)(pt 1):239–244.PubMedGoogle Scholar
  4. 4.
    Hayreh SS. Optic disc edema in raised intracranial pressure. VI. Associated visual disturbances and their pathogenesis. Arch Ophthalmol 1977; 95(9):1566–1579.PubMedGoogle Scholar
  5. 5.
    Cogan DG, Kuwabara T. Papilledema. Exp Eye Res 1977;25(suppl):419–433.PubMedCrossRefGoogle Scholar
  6. 6.
    Kosmorsky G. Pseudotumor cerebri. Neurosurg Clin N Am 2001;12(4):775–797.PubMedGoogle Scholar
  7. 7.
    Miller NR. Papilledema. In: Miller NR, Newman NJ, editors. Walsh and Hoyt’s clinical neuroophthalmology, 5th ed., vol. 1. Baltimore: Williams & Wilkins; 1998. p. 487–548.Google Scholar
  8. 8.
    Spalton DJ, Hitchings, RA, Hunter PA, editors; Tan JCH, associate editor; Harry J, pathology advisor. Atlas of clinical ophthalmology. Philadelphia, Edinburgh: Elsevier Mosby; 2005.Google Scholar
  9. 9.
    Griebel SR, Kosmorsky GS. Choroidal folds associated with increased intracranial pressure. Am J Ophthalmol 2000;129(4):513–516.PubMedCrossRefGoogle Scholar
  10. 10.
    Talks SJ, Mossa F, Elston JS. The contribution of macular changes to visual loss in benign intracranial hypertension. Eye 1998;12(pt 5):806–808.PubMedGoogle Scholar
  11. 11.
    Keane JR. Papilledema with unusual ocular hemorrhages. Arch Ophthalmol 1981;99(2): 262–263.PubMedGoogle Scholar
  12. 12.
    McCasland BJ, Mendicino ME, Newman NJ. Subretinal haemorrhage in idiopathic intracranial hypertension. Br J Ophthalmol 1999;83(7): 883–884.PubMedGoogle Scholar
  13. 13.
    Hedges TR III, Legge RH, Peli E, Yardley CJ. Retinal nerve fiber layer changes and visual field loss in idiopathic intracranial hypertension. Ophthalmology 1995;102(8):1242–1247.PubMedGoogle Scholar
  14. 14.
    Fischer F. Zur frage sog. Permanenter strungspapille. Klin Mbl Augenheilkd 1939; 102:656–663.Google Scholar
  15. 15.
    Schreiber S, Bischoff P. Beidseitige opticusatrophie bei pseudotumor cerebri. Klin Mbl Augenheilkd 1983;182:465–467.Google Scholar
  16. 16.
    Neetens A, Smets RM. Papilledema. Neuro-Ophthalmology 1989;9:81–101.CrossRefGoogle Scholar
  17. 17.
    Carter SR, Seiff SR. Macular changes in pseudotumor cerebri before and after optic nerve sheath fenestration. Ophthalmology 1995; 102(6):937–941.PubMedGoogle Scholar
  18. 18.
    Eggers HM, Sanders MD. Acquired optociliary shunt vessels in papilloedema. Br J Ophthalmol 1980;64(4):267–271.PubMedCrossRefGoogle Scholar
  19. 19.
    Hedges TR. Papilledema: its recognition and relation to increased intracranial pressure. Surv Ophthalmol 1975;19(4):201–223.PubMedGoogle Scholar
  20. 20.
    Henkind P, Benjamin JV. Vascular anomalies and neoplasms of the optic nerve head. Trans Ophthalmol Soc U K 1976;96(3):418–423.PubMedGoogle Scholar
  21. 21.
    Anderson RL, Flaharty PM. Treatment of pseudotumor cerebri by primary and secondary optic nerve sheath decompression. Am J Ophthalmol 1992;113(5):599–601.PubMedGoogle Scholar
  22. 22.
    Levin PS, Newman SA, Quigley HA, Miller NR. A clinicopathologic study of optic neuropathies associated with intracranial mass lesions with quantification of remaining axons. Am J Ophthalmol 1983;95(3):295–306.PubMedGoogle Scholar
  23. 23.
    Lepore FE. Unilateral and highly asymmetric papilledema in pseudotumor cerebri. Neurology 1992;42(3 pt 1):676–678.PubMedGoogle Scholar
  24. 24.
    Moster ML, Slavin M, Wall M. Unilateral disk edema in a young woman. Surv Ophthalmol 1995;39(5):409–416.PubMedCrossRefGoogle Scholar
  25. 25.
    Sher NA, Wirtschafter J, Shapiro SK, See C, Shapiro I. Unilateral papilledema in ‘benign’ intracranial hypertension (pseudotumor cerebri). JAMA 1983;250(17):2346–2347.PubMedCrossRefGoogle Scholar
  26. 26.
    Strominger MB, Weiss GB, Mehler MF. Asymptomatic unilateral papilledema in pseudotumor cerebri. J Clin Neuro-Ophthalmol 1992;12(4):238–241.Google Scholar
  27. 27.
    Paul TO, Hoyt WF. Funduscopic appearance of papilledema with optic tract atrophy. Arch Ophthalmol 1976;94(3):467–468.PubMedGoogle Scholar
  28. 28.
    Hayreh SS. Pathogenesis of oedema of the optic disc (papilloedema): a preliminary report. Br J Ophthalmol 1964;48:522–543.PubMedCrossRefGoogle Scholar
  29. 29.
    Krishna R, Kosmorsky GS, Wright KW. Pseudotumor cerebri sine papilledema with unilateral sixth nerve palsy. J Neuro-Ophthalmol 1998; 18(1):53–55.CrossRefGoogle Scholar
  30. 30.
    Liu GT, Volpe NJ, Schatz NJ, Galetta SL, Farrar JT, Raps EC. Severe sudden visual loss caused by pseudotumor cerebri and lumboperitoneal shunt failure. Am J Ophthalmol 1996;122(1): 129–131.PubMedGoogle Scholar
  31. 31.
    Repka MX, Miller NR, Savino PJ. Pseudotumor cerebri. Am J Ophthalmol 1984;98(6):741–746.PubMedGoogle Scholar
  32. 32.
    Wall M, Hart WM Jr, Burde RM. Visual field defects in idiopathic intracranial hypertension (pseudotumor cerebri). Am J Ophthalmol 1983; 96(5):654–669.PubMedGoogle Scholar
  33. 33.
    Hayreh SS, Hayreh MS. Optic disc edema in raised intracranial pressure. II. Early detection with fluorescein fundus angiography and stereoscopic color photography. Arch Ophthalmol 1977;95(7):1245–1254.PubMedGoogle Scholar
  34. 34.
    Sanders MD, Ffytche TJ. Fluorescein angiography in the diagnosis of drusen of the disc. Trans Ophthalmol Soc U K 1967;87:457–468.PubMedGoogle Scholar
  35. 35.
    Salgarello T, Tamburrelli C, Falsini B, Giudiceandrea A, Colotto A. Optic nerve diameters and perimetric thresholds in idiopathic intracranial hypertension. Br J Ophthalmol 1996; 80(6):509–514.PubMedCrossRefGoogle Scholar
  36. 36.
    Zimmerman LE. Histology and general pathology of the optic nerve. Trans Am Acad Ophthalmol Otolaryngol 1956;60(1):14–30.PubMedGoogle Scholar
  37. 37.
    Reese AB. Peripapillary detachment of the retina accompanying papilledema. Trans Am Ophthalmol Soc 1930;28:341–351.PubMedGoogle Scholar
  38. 38.
    Corbett JJ, Jacobson DM, Mauer RC, Thompson HS. Enlargement of the blind spot caused by papilledema. Am J Ophthalmol 1988;105(3): 261–265.PubMedGoogle Scholar
  39. 39.
    Ashton N. The eye in malignant hypertension. Trans Am Acad Ophthalmol Otolaryngol 1972;76(1):17–40.PubMedGoogle Scholar
  40. 40.
    Hayreh SS. Pathogenesis of oedema of the optic disc. Doc Ophthalmol 1968;24(2):289–411.PubMedCrossRefGoogle Scholar
  41. 41.
    Hayreh SS. Blood supply of the optic nerve head and its role in optic atrophy, glaucoma, and oedema of the optic disc. Br J Ophthalmol 1969;53(11):721–748.PubMedCrossRefGoogle Scholar
  42. 42.
    Tso MO, Hayreh SS. Optic disc edema in raised intracranial pressure. IV. Axoplasmic transport in experimental papilledema. Arch Ophthalmol 1977;95(8):1458–1462.PubMedGoogle Scholar
  43. 43.
    Orcutt JC, Page NG, Sanders MD. Factors affecting visual loss in benign intracranial hypertension. Ophthalmology 1984;91(11): 1303–1312.PubMedGoogle Scholar
  44. 44.
    Petrohelos MA, Henderson JW. The ocular findings of intracranial tumor. A study of 358 cases. Trans Am Acad Ophthalmol Otolaryngol 1950;Nov–Dec:89–98.Google Scholar
  45. 45.
    Bergelsen TI. The premature synostosis of the cranial sutures. Acta Ophthalmol (Copenh) 1958;36(suppl 51):1–176.Google Scholar
  46. 46.
    Krayenbul H, Yasargil MG. Das Hirnaneurysma. Basel: Geigy; 1958.Google Scholar
  47. 47.
    Margolis G, Kilham L. Hydrocephalus in hamsters, ferrets, rats, and mice following inoculations with reovirus type I. II. Pathologic studies. Lab Invest 1969;21(3):189–198.Google Scholar
  48. 48.
    Hanna LS, Girgis NI, Yassin MMW, et al. Incidence of papilledema and optic atrophy in meningitis. Jpn J Ophthalmol 1981;25:69–73.Google Scholar
  49. 49.
    Miller JD, Ross CA. Encephalitis. A four-year survey. Lancet 1968;1(7552):1121–1126.PubMedCrossRefGoogle Scholar
  50. 50.
    Silverstein A. Papilledema with acute viral infections of the brain. Mt Sinai J Med 1974; 41(3):435–443.PubMedGoogle Scholar
  51. 51.
    Haslbeck KM, Eberhardt KE, Nissen U, et al. Intracranial hypertension as a clinical manifestation of cauda equine paraganglioma. Neurology 1999;52(6):1297–1298.PubMedGoogle Scholar
  52. 52.
    Fantin A, Feist RM, Reddy CV. Intracranial hypertension and papilloedema in chronic inflammatory demyelinating polyneuropathy. Br J Ophthalmol 1993;77(3):193.PubMedCrossRefGoogle Scholar
  53. 53.
    Ameri A, Bousser MG. Cerebral venous thrombosis. Neurol Clin 1992;10(1):87–111.PubMedGoogle Scholar
  54. 54.
    Bousser MG, Barnett HJM. Cerebral venous thrombosis. In: Bousser MG, Barnett HJM. Stroke: pathophysiology, diagnosis, and management, 2nd ed. New York: Churchill-Livingstone; 1992. p. 517–537.Google Scholar
  55. 55.
    Bousser MG, Chiras J, Bories J, Castaigne P. Cerebral venous thrombosis: a review of 38 cases. Stroke 1985;16(2):199–213.PubMedGoogle Scholar
  56. 56.
    Buonanno FS. Cerebral sinovenous thrombosis. Curr Treat Options Cardiovasc Med 2001;3(5): 417–427.PubMedCrossRefGoogle Scholar
  57. 57.
    Provenzale JM, Joseph GJ, Barboriak DP. Dural sinus thrombosis: findings on CT and MR imaging and diagnostic pitfalls. AJR Am J Roentgenol 1998;170(3):777–783.PubMedGoogle Scholar
  58. 58.
    Biousse V, Tong F, Newman NJ. Cerebral venous thrombosis. Curr Treat Options Neurol 2003; 5(5):409–420.PubMedCrossRefGoogle Scholar
  59. 59.
    Villringer A, Mehraein S, Einhaupl KM. Pathophysiological aspects of cerebral sinus venous thrombosis (SVT). J Neuroradiol 1994;21(2): 72–80.PubMedGoogle Scholar
  60. 60.
    Bousser MG, Russell RR. Cerebral venous thrombosis. London: Saunders; 1997.Google Scholar
  61. 61.
    Allroggen H, Abbott RJ. Cerebral venous sinus thrombosis. Postgrad Med J. 2000;76(891): 12–15.PubMedCrossRefGoogle Scholar
  62. 62.
    de Bruijn SF, Stam J. Randomized, placebocontrolled trial of anticoagulant treatment with low-molecular-weight heparin for cerebral sinus thrombosis. Stroke 1999;30(3):484–488.PubMedGoogle Scholar
  63. 63.
    Preter M, Tzourio C, Ameri A, Bousser MG. Long-term prognosis in cerebral venous thrombosis. Follow-up of 77 patients. Stroke 1996; 27(2):243–246.PubMedGoogle Scholar
  64. 64.
    Ozsvath RR, Casey SO, Lustrin ES, Alberico RA, Hassankhani A, Patel M. Cerebral venography: comparison of CT and MR projection venography. AJR Am J Roentgenol 1997; 169(6):1699–1707.PubMedGoogle Scholar
  65. 65.
    Deschiens MA, Conard J, Horellou MH, et al. Coagulation studies, factor V Leiden, and anticardiolipin antibodies in 40 cases of cerebral venous thrombosis. Stroke 1996;27(10): 1724–1730.PubMedGoogle Scholar
  66. 66.
    Stam J, De Bruijn SF, De Veber G. Anticoagulation for cerebral sinus thrombosis. Cochrane Database Syst Rev 2002;4:CD002005.Google Scholar
  67. 67.
    Einhaupl KM, Masuhr F. Cerebral sinus and venous thrombosis. Ther Umsch 1996;53(7): 552–558.PubMedGoogle Scholar
  68. 68.
    Stanley TV. Idiopathic intracranial hypertension presenting as hemiplegic migraine. Acta Paediatr 2002;91(8):980–982.PubMedCrossRefGoogle Scholar
  69. 69.
    Friedman DI, Rausch EA. Headache diagnoses in patients with treated idiopathic intracranial hypertension. Neurology 2002;58(10):1551–1553.PubMedGoogle Scholar
  70. 70.
    Bandyopadhyay S, Jacobson DM. Clinical features of late-onset pseudotumor cerebri ful-filling the modified dandy criteria. J Neuro-Ophthalmol 2002;22(1):9–11.CrossRefGoogle Scholar
  71. 71.
    Mathew NT, Ravishankar K, Sanin LC. Coexistence of migraine and idiopathic intracranial hypertension without papilledema. Neurology 1996;46(5):1226–1230.PubMedGoogle Scholar
  72. 72.
    Evans RW. New daily persistent headache. Curr Pain Headache Rep 2003;7(4):303–307.PubMedCrossRefGoogle Scholar
  73. 73.
    Digre KB, Corbett JJ. Idiopathic intracranial hypertension (pseudotumor cerebri): a reappraisal. Neurology 2001;7:2–67.CrossRefGoogle Scholar
  74. 74.
    Green JP, Newman NJ, Stowe ZN, Nemeroff CB. “Normal pressure” pseudotumor cerebri. J Neuro-Ophthalmol 1996;16(4):241–246.CrossRefGoogle Scholar
  75. 75.
    Dhiravibulya K, Ouvrier R, Johnston I, Procopis P, Antony J. Benign intracranial hypertension in childhood: a review of 23 patients. J Paediatr Child Health 1991;27(5):304–307.PubMedCrossRefGoogle Scholar
  76. 76.
    Baker RS, Carter D, Hendrick EB, Buncic JR. Visual loss in pseudotumor cerebri of childhood. A follow-up study. Arch Ophthalmol 1985;103(11):1681–1686.PubMedGoogle Scholar
  77. 77.
    Durcan FJ, Corbett JJ, Wall M. The incidence of pseudotumor cerebri. Population studies in Iowa and Louisiana. Arch Neurol 1988;45(8):875–877.PubMedGoogle Scholar
  78. 78.
    Radhakrishnan K, Sridharan R, Ashok PP, Mousa ME. Pseudotumour cerebri: incidence and pattern in North-Eastern Libya. Eur Neurol 1986;25(2):117–124.PubMedCrossRefGoogle Scholar
  79. 79.
    Radhakrishnan K, Thacker AK, Bohlaga NH, Maloo JC, Gerryo SE. Epidemiology of idiopathic intracranial hypertension: a prospective and casecontrol study. J Neurol Sci 1993;116(1):18–28.PubMedGoogle Scholar
  80. 80.
    Wall M, Dollar JD, Sadun AA, Kardon R. Idiopathic intracranial hypertension. Lack of histologic evidence for cerebral edema. Arch Neurol 1995;52(2):141–145.PubMedGoogle Scholar
  81. 81.
    Rowe FJ, Sarkies NJ. Assessment of visual function in idiopathic intracranial hypertension: a prospective study. Eye 1998;12(pt 1):111–118.PubMedGoogle Scholar
  82. 82.
    Wall M, White WN II. Asymmetric papilledema in idiopathic intracranial hypertension: prospective interocular comparison of sensory visual function. Invest Ophthalmol Visual Sci. 1998;39(1):134–142.Google Scholar
  83. 83.
    Foley J. Benign forms of intracranial hypertension; toxic and otitic hydrocephalus. Brain 1955;78(1):1–41.PubMedCrossRefGoogle Scholar
  84. 84.
    Corbett JJ, Savino PJ, Thompson HS, et al. Visual loss in pseudotumor cerebri. Follow-up of 57 patients from five to 41 years and a profile of 14 patients with permanent severe visual loss. Arch Neurol 1982;39(8):461–474.PubMedGoogle Scholar
  85. 85.
    Wall M, George D. Idiopathic intracranial hypertension. Aprospective study of 50 patients. Brain 1991;114(pt 1A):155–180.PubMedCrossRefGoogle Scholar
  86. 86.
    Rowe FJ, Sarkies NJ. The relationship between obesity and idiopathic intracranial hypertension. Int J Obes Relat Metab Disord 1999;23(1): 54–59.PubMedCrossRefGoogle Scholar
  87. 87.
    Johnson LN, Krohel GB, Madsen RW, March GA Jr. The role of weight loss and acetazolamide in the treatment of idiopathic intracranial hypertension (pseudotumor cerebri). Ophthalmology 1998;105(12):2313–2317.PubMedCrossRefGoogle Scholar
  88. 88.
    Kupersmith MJ, Gamell L, Turbin R, Peck V, Spiegel P, Wall M. Effects of weight loss on the course of idiopathic intracranial hypertension in women. Neurology 1998;50(4):1094–1098.PubMedGoogle Scholar
  89. 89.
    Donaldson JO. Pathogenesis of pseudotumor cerebri syndromes. Neurology 1981;31(7):877–880.PubMedGoogle Scholar
  90. 90.
    Dandy WE. Intracranial pressure without brain tumor: diagnosis and treatment. Ann Surg 1937; 106:492–513.PubMedCrossRefGoogle Scholar
  91. 91.
    Raichle ME, Grubb RL Jr, Phelps ME, Gado MH, Caronna JJ. Cerebral hemodynamics and metabolism in pseudotumor cerebri. Ann Neurol 1978;4(2):104–111.PubMedCrossRefGoogle Scholar
  92. 92.
    Gideon P, Sorensen PS, Thomsen C, Stahlberg F, Gjerris F, Henriksen O. Increased brain water self-diffusion in patients with idiopathic intracranial hypertension. AJNR Am J Neuroradiol 1995;16(2):381–387.PubMedGoogle Scholar
  93. 93.
    Moser FG, Hilal SK, Abrams G, Bello JA, Schipper H, Silver AJ. MR imaging of pseudotumor cerebri. AJR Am J Roentgenol 1988; 150(4):903–909.PubMedGoogle Scholar
  94. 94.
    Sorensen PS, Thomsen C, Gjerris F, Henriksen O. Brain water accumulation in pseudotumour cerebri demonstrated by MR-imaging of brain water self-diffusion. Acta Neurochir Suppl (Wien) 1990;51:363–365.Google Scholar
  95. 95.
    Sorensen PS, Thomsen C, Gjerris F, Schmidt J, Kjaer L, Henriksen O. Increased brain water content in pseudotumour cerebri measured by magnetic resonance imaging of brain water self diffusion. Neurol Res 1989;11(3):160–164.PubMedGoogle Scholar
  96. 96.
    Johnston I, Paterson A. Benign intracranial hypertension. II. CSF pressure and circulation. Brain 1974;97(2):301–312.PubMedCrossRefGoogle Scholar
  97. 97.
    Rottenberg DA, Foley KM, Posner JB. Hypothesis: the pathogenesis of pseudotumor cerebri. Med Hypotheses 1980;6(9):9138.CrossRefGoogle Scholar
  98. 98.
    Janny P, Chazal J, Colnet G, Irthum B, Georget AM. Benign intracranial hypertension and disorders of CSF absorption. Surg Neurol 1981; 15(3):168–174.PubMedCrossRefGoogle Scholar
  99. 99.
    Karahalios DG, Rekate HL, Khayata MH, Apostolides PJ. Elevated intracranial venous pressure as a universal mechanism in pseudotumor cerebri of varying etiologies. Neurology 1996;46(1):198–202.PubMedGoogle Scholar
  100. 100.
    Farb RI, Vanek I, Scott JN, et al. Idiopathic intracranial hypertension: the prevalence and morphology of sinovenous stenosis. Neurology 2003;60(9):1418–1424.PubMedGoogle Scholar
  101. 101.
    Sumbranian RM, Tress BM, King JO, Eizenberg N, Mitchell PJ. Transverse sinus septum: a new aetiology of idiopathic intracranial hypertension? Australas Radiol 2004;48:114.CrossRefGoogle Scholar
  102. 102.
    Sugerman HJ, DeMaria EJ, Felton WL III, Nakatsuka M, Sismanis A. Increased intraabdominal pressure and cardiac filling pressures in obesity-associated pseudotumor cerebri. Neurology 1997;49(2):507–511.PubMedGoogle Scholar
  103. 103.
    Sugerman HJ, Felton WL III, Salvant JB Jr, Sismanis A, Kellum JM. Effects of surgically induced weight loss on idiopathic intracranial hypertension in morbid obesity. Neurology 1995;45(9):1655–1659.PubMedGoogle Scholar
  104. 104.
    Sugerman HJ, Felton WL III, Sismanis A, Kellum JM, DeMaria EJ, Sugerman EL. Gastric surgery for pseudotumor cerebri associated with severe obesity. Ann Surg 1999;229(5): 634–640; discussion 640-2.PubMedCrossRefGoogle Scholar
  105. 105.
    Brockmeier B, Burbach H, Runge M, Altenkirch H. Raised intracranial pressure in chronic respiratory disease. Lancet 1997;349(9055):883.PubMedCrossRefGoogle Scholar
  106. 106.
    Jennum P, Borgesen SE. Intracranial pressure and obstructive sleep apnea. Chest 1989;95(2): 279–283.PubMedCrossRefGoogle Scholar
  107. 107.
    McNamara ME. Idiopathic intracranial hypertension without papilledema: related to sleep apnea? Arch Neurol 1992;49(1):14.PubMedGoogle Scholar
  108. 108.
    Lampl Y, Eshel Y, Kessler A, et al. Serum leptin level in women with idiopathic intracranial hypertension. J Neurol Neurosurg Psychiatry 2002;72(5):642–643.PubMedCrossRefGoogle Scholar
  109. 109.
    Subramanian PS, Goldenberg-Cohen N, Shukla S, Cheskin LJ, Miller NR. Plasma ghrelin levels are normal in obese patients with idiopathic intracranial hypertension (pseudotumor cerebri). Am J Ophthalmol 2004;138(1):109–113.PubMedCrossRefGoogle Scholar
  110. 110.
    Carlow TJ, Glaser JS. Pseudotumor cerebri syndrome in systemic lupus erythematosus. JAM 1974;228(2):197–200.CrossRefGoogle Scholar
  111. 111.
    Li EK, Ho PC. Pseudotumor cerebri in systemic lupus erythematosus. J Rheumatol 1989;16(1): 113–116.PubMedGoogle Scholar
  112. 112.
    Padeh S, Passwell JH. Systemic lupus erythematosus presenting as idiopathic intracranial hypertension. J Rheumatol 1996;23(7):1266–1268.PubMedGoogle Scholar
  113. 113.
    Waxman J, Wasan H. The architecture of cancer. BMJ 1992;305(6865):1306–1307.PubMedCrossRefGoogle Scholar
  114. 114.
    Capriles LF. Intracranial hypertension and irondeficiency anemia: report of four cases. Arch Neurol 1963;9:147–153.PubMedGoogle Scholar
  115. 115.
    Condulis N, Germain G, Charest N, Levy S, Carpenter TO. Pseudotumor cerebri: a presenting manifestation of Addison’s disease. Clin Pediatr (Phila) 1997;36(12):711–713.Google Scholar
  116. 116.
    Cantu C, Barinagarrementeria F. Cerebral venous thrombosis associated with pregnancy and puerperium. Review of 67 cases. Stroke 1993;24(12):1880–1884.PubMedGoogle Scholar
  117. 117.
    Huseman CA, Torkelson RD. Pseudotumor cerebri following treatment of hypothalamic and primary hypothyroidism. Am J Dis Child 1984;138(10):927–931.PubMedGoogle Scholar
  118. 118.
    Raghavan S, DiMartino-Nardi J, Saenger P, Linder B. Pseudotumor cerebri in an infant after l-thyroxine therapy for transient neonatal hypothyroidism. J Pediatr 1997;130(3):478–480.PubMedCrossRefGoogle Scholar
  119. 119.
    Chang D, Nagamoto G, Smith WE. Benign intracranial hypertension and chronic renal failure. Cleve Clin J Med 1992;59(4):419–422.PubMedGoogle Scholar
  120. 120.
    Guy J, Johnston PK, Corbett JJ, Day AL, Glaser JS. Treatment of visual loss in pseudotumor cerebri associated with uremia. Neurology 1990;40(1):28–32.PubMedGoogle Scholar
  121. 121.
    Noetzel MJ, Rioux SD. Pseudotumor cerebri associated with obstructive nephropathy. Pediatr Neurol 1986;2(4):238–240.PubMedCrossRefGoogle Scholar
  122. 122.
    Couban S, Maxner CE. Cerebral venous sinus thrombosis presenting as idiopathic intracranial hypertension. Can Med Assoc J 1991; 145(6):657–659.Google Scholar
  123. 123.
    Biousse V, Ameri A, Bousser MG. Isolated intracranial hypertension as the only sign of cerebral venous thrombosis. Neurology 1999; 53(7):1537–1542.PubMedGoogle Scholar
  124. 124.
    Cognard C, Casasco A, Toevi M, Houdart E, Chiras J, Merland JJ. Dural arteriovenous fistulas as a cause of intracranial hypertension due to impairment of cranial venous outflow. J Neurol Neurosurg Psychiatry 1998;65(3): 308–316.PubMedGoogle Scholar
  125. 125.
    Halbach VV, Higashida RT, Hieshima GB. Interventional neuroradiology. AJR Am J Roentgenol 1989;153(3):467–476.PubMedGoogle Scholar
  126. 126.
    Vijayan N. Headache following removal of acoustic neuroma. Headache 1995;35(10):639.PubMedCrossRefGoogle Scholar
  127. 127.
    Kiers L, King JO. Increased intracranial pressure following bilateral neck dissection and radiotherapy. Aust N Z J Surg. 1991;61(6): 459–461.PubMedCrossRefGoogle Scholar
  128. 128.
    Lam BL, Schatz NJ, Glaser JS, Bowen BC. Pseudotumor cerebri from cranial venous obstruction. Ophthalmology 1992;99(5):706–712.PubMedGoogle Scholar
  129. 129.
    Sklar FH, Beyer CW Jr, Ramanathan M, Cooper PR, Clark WK. Cerebrospinal fluid dynamics in patients with pseudotumor cerebri. Neurosurgery 1979;5(2):208–216.PubMedCrossRefGoogle Scholar
  130. 130.
    Birdwell BG, Yeager R, Whitsett TL. Pseudotumor cerebri. A complication of catheter-induced subclavian vein thrombosis. Arch Intern Med 1994;154(7):808–811.PubMedCrossRefGoogle Scholar
  131. 131.
    Marr WG, Chambers JW. Occlusion of the cerebral dural sinuses by tumor simulating pseudotumor cerebri. Am J Ophthalmol 1966;61(1):45–49.PubMedGoogle Scholar
  132. 132.
    Lee AG, Brazis PW. Magnetic resonance venography in idiopathic pseudotumor cerebri. J Neuro-Ophthalmol 2000;20(1):12–13.CrossRefGoogle Scholar
  133. 133.
    Wasan H, Mansi JL, Benjamin S, Powles R, Cunningham D. Myeloma and benign intracranial hypertension. BMJ 1992;304(6828):685.PubMedGoogle Scholar
  134. 134.
    Pasquale LR, Moster ML, Schmaier A. Dural sinus thrombosis with abnormalities of protein S and fibrinogen. Arch Ophthalmol 1990;108(5):644.PubMedGoogle Scholar
  135. 135.
    Ludemann P, Nabavi DG, Junker R, et al. Factor V Leiden mutation is a risk factor for cerebral venous thrombosis: a case-control study of 55 patients. Stroke 1998;29(12):2507–2510.PubMedGoogle Scholar
  136. 136.
    Weih M, Vetter B, Ziemer S, et al. Increased rate of factor V Leiden mutation in patients with cerebral venous thrombosis. J Neurol 1998;245(3):149–152.PubMedCrossRefGoogle Scholar
  137. 137.
    Leker RR, Steiner I. Anticardiolipin antibodies are frequently present in patients with idiopathic intracranial hypertension. Arch Neurol 1998;55(6):817–820.PubMedCrossRefGoogle Scholar
  138. 138.
    Mokri B, Jack CR Jr, Petty GW. Pseudotumor syndrome associated with cerebral venous sinus occlusion and antiphospholipid antibodies. Stroke 1993;24(3):469–472.PubMedGoogle Scholar
  139. 139.
    Walsh FB, Clark DB, Thompson RS, Nicholson DH. Oral contraceptives and neuro-ophthalmologic interest. Arch Ophthalmol 1965;74(5): 628–640.PubMedGoogle Scholar
  140. 140.
    Glueck CJ, Iyengar S, Goldenberg N, Smith LS, Wang P. Idiopathic intracranial hypertension: associations with coagulation disorders and polycystic-ovary syndrome. J Lab Clin Med 2003;142(1):35–45.PubMedCrossRefGoogle Scholar
  141. 141.
    Bousser MG. Cerebral venous thrombosis: diagnosis and management. J Neurol 2000; 247(4):252–258.PubMedCrossRefGoogle Scholar
  142. 142.
    Biousse V, Rucker JC, Vignal C, Crassard I, Katz BJ, Newman NJ. Anemia and papilledema. Am J Ophthalmol 2003;135(4):437–446.PubMedCrossRefGoogle Scholar
  143. 143.
    Henry M, Driscoll MC, Miller M, Chang T, Minniti CP. Pseudotumor cerebri in children with sickle cell disease: a case series. Pediatrics 2004;113(3 pt 1):e265–e269.PubMedCrossRefGoogle Scholar
  144. 144.
    Lee AG, Golnik K, Kardon R, Wall M, Eggenberger E, Yedavally S. Sleep apnea and intracranial hypertension in men. Ophthalmology 2002;109(3):482–485.PubMedCrossRefGoogle Scholar
  145. 145.
    Weber KT. Perspective: shifting sands. What gives? Am J Med Sci 2002;324(6):291–295.PubMedCrossRefGoogle Scholar
  146. 146.
    Frost N, Lee MS, Sweeney P. Myxedema, papilledema, and elevated CSF protein. Neurology 2004;63(4):754–755.PubMedGoogle Scholar
  147. 147.
    Villain MA, Pageaux GP, Veyrac M, Arnaud B, Harris A, Greenfield DS. Effect of acetazolamide on ocular hemodynamics in pseudotumor cerebri associated with inflammatory bowel disease. Am J Ophthalmol 2002;134(5): 778–780.PubMedCrossRefGoogle Scholar
  148. 148.
    Tillman O, Kaiser HJ, Killer HE. Pseudotumor cerebri in a patient with Goldenhar’s and Duane’s syndromes. Ophthalmologica 2002; 216(4):296–299.PubMedCrossRefGoogle Scholar
  149. 149.
    Mokri B. Intracranial hypertension after treatment of spontaneous cerebrospinal fluid leaks. Mayo Clin Proc 2002;77(11):1241–1246.PubMedGoogle Scholar
  150. 150.
    Morrice G. Papilledema and hypervitaminosis A. JAMA 1970;213(8):1344.PubMedCrossRefGoogle Scholar
  151. 151.
    Roytman M, Frumkin A, Bohn TG. Pseudotumor cerebri caused by isotretinoin. Cutis 1988;42(5):399–400.PubMedGoogle Scholar
  152. 152.
    Spector RH, Carlisle J. Pseudotumor cerebri caused by a synthetic vitamin A preparation. Neurology 1984;34(11):1509–1511.PubMedGoogle Scholar
  153. 153.
    Naderi S, Nukala S, Marruenda F, Kudarvalli P, Koduri PR. Pseudotumour cerebri in acute promyelocytic leukemia: improvement despite continued ATRA therapy. Ann Hematol 1999; 78(7):333–334.PubMedCrossRefGoogle Scholar
  154. 154.
    Visani G, Bontempo G, Manfroi S, Pazzaglia A, D’Alessandro R, Tura S. All-trans-retinoic acid and pseudotumor cerebri in a young adult with acute promyelocytic leukemia: a possible disease association. Haematologica 1996;81(2): 152–154.PubMedGoogle Scholar
  155. 155.
    Visani G, Manfroi S, Tosi P, Martinelli G. Alltrans-retinoic acid and pseudotumor cerebri. Leuk Lymphoma 1996;23(5–6):437–442.PubMedCrossRefGoogle Scholar
  156. 156.
    Chiu AM, Chuenkongkaew WL, Cornblath WT, et al. Minocycline treatment and pseudotumor cerebri syndrome. Am J Ophthalmol 1998; 126(1):116–121.PubMedCrossRefGoogle Scholar
  157. 157.
    Giles CL, Soble AR. Intracranial hypertension and tetracycline therapy. Am J Ophthalmol 1971;72(5):981–982.PubMedGoogle Scholar
  158. 158.
    Friedman DI, Gordon LK, Egan RA, et al. Doxycycline and intracranial hypertension. Neurology 2004;62(12):2297–2299.PubMedGoogle Scholar
  159. 159.
    Cohen DN. Intracranial hypertension and papilledema associated with nalidixic acid therapy. Am J Ophthalmol 1973;76(5):680–682.PubMedGoogle Scholar
  160. 160.
    Getenet JC, Croisile B, Vighetto A, et al. Idiopathic intracranial hypertension after ofloxacin treatment. Acta Neurol Scand 1993; 87(6):503–504.PubMedGoogle Scholar
  161. 161.
    Winrow AP, Supramaniam G. Benign intracranial hypertension after ciprofloxacin administration. Arch Dis Child 1990;65(10):1165–1166.PubMedGoogle Scholar
  162. 162.
    Ch’ien LT. Intracranial hypertension and sulfamethoxazole. N Engl J Med 1976;283:47.Google Scholar
  163. 163.
    Sunku AJ, O’Duffy AE, Swanson JW. Benign intracranial hypertension associated with levonorgestrel implants. Ann Neurol 1993;34:299.Google Scholar
  164. 164.
    Hamed LM, Glaser JS, Schatz NJ, Perez TH. Pseudotumor cerebri induced by danazol. Am J Ophthalmol 1989;107(2):105–110.PubMedGoogle Scholar
  165. 165.
    Neville BGR, Wilson J. Benign intracranial hypertension following corticosteroid with-drawal in childhood. Br Med J 1970;3:554–556.PubMedGoogle Scholar
  166. 166.
    Levine SH, Puchalski C. Pseudotumor cerebri associated with lithium therapy in two patients. J Clin Psychiatry 1990;51(6):251–253.PubMedGoogle Scholar
  167. 167.
    Saul RF, Hamburger HA, Selhorst JB. Pseudotumor cerebri secondary to lithium carbonate. JAMA 1985;253(19):2869–2870.PubMedCrossRefGoogle Scholar
  168. 168.
    Serratrice J, Granel B, Conrath J, et al. Benign intracranial hypertension and thyreostimulin suppression hormonotherapy. Am J Ophthalmol 2002;134(6):910–911.PubMedCrossRefGoogle Scholar
  169. 169.
    Rosa N, Giamundo A, Jura A, Iaccarino G, Romano A. Mesalazine-associated benign intracranial hypertension in a patient with ulcerative colitis. Am J Ophthalmol 2003; 136(1):212–213.PubMedCrossRefGoogle Scholar
  170. 170.
    Corbett JJ. Medical-induced pseudotumor cerebri [lecture]. The North American Neuro-Ophthalmology Society Annual Meeting; 2006, Tucson, AZ.Google Scholar
  171. 171.
    Jacobson DM, Berg R, Wall M, Digre KB, Corbett JJ, Ellefson RD. Serum vitamin A concentration is elevated in idiopathic intracranial hypertension. Neurology 1999;53(5):1114–1118.PubMedGoogle Scholar
  172. 172.
    Crock PA, McKenzie JD, Nicoll AM, et al. Benign intracranial hypertension and recombinant growth hormone therapy in Australia and New Zealand. Acta Paediatr 1998;87(4): 381–386.PubMedCrossRefGoogle Scholar
  173. 173.
    Rogers AH, Rogers GL, Bremer DL, McGregor ML. Pseudotumor cerebri in children receiving recombinant human growth hormone. Ophthalmology 1999;106(6):1186–1189; discussion 1189-90.PubMedCrossRefGoogle Scholar
  174. 174.
    Wessel K, Thron A, Linden D, Petersen D, Dichgans J. Pseudotumor cerebri: clinical and neuroradiological findings. Eur Arch Psychiatry Neurol Sci 1987;237(1):54–60.PubMedCrossRefGoogle Scholar
  175. 175.
    Jacobson DM, Karanjia PN, Olson KA, Warner JJ. Computed tomography ventricular size has no predictive value in diagnosing pseudotumor cerebri. Neurology 1990;40(9):1454–1455.PubMedGoogle Scholar
  176. 176.
    Brodsky MC, Vaphiades M. Magnetic resonance imaging in pseudotumor cerebri. Ophthalmology 1998;105(9):1686–1693.PubMedCrossRefGoogle Scholar
  177. 177.
    Hannerz J, Greitz D, Ericson K. Is there a relationship between obesity and intracranial hypertension? Int J Obes Relat Metab Disord 1995;19(4):240–244.PubMedGoogle Scholar
  178. 178.
    Czosnyka M, Pickard JD. Monitoring and interpretation of intracranial pressure. J Neurol Neurosurg Psychiatry 2004;75(6):813–821.PubMedCrossRefGoogle Scholar
  179. 179.
    Friedman DI, Jacobson DM. Idiopathic intracranial hypertension. J Neuro-Ophthalmol 2004;24(2):138–145.CrossRefGoogle Scholar
  180. 180.
    Rubin RC, Henderson ES, Ommaya AK, Walker MD, Rall DP. The production of cerebrospinal fluid in man and its modification by acetazolamide. J Neurosurg 1966;25(4):430–436.PubMedGoogle Scholar
  181. 181.
    Physicians’ desk reference, 58th ed. Montvale: Thomson PDR; 2004. Diamox; p. 1208–1209.Google Scholar
  182. 182.
    Schoeman JF. Childhood pseudotumor cerebri: clinical and intracranial pressure response to acetazolamide and furosemide treatment in a case series. J Child Neurol 1994;9(2):130–134.PubMedGoogle Scholar
  183. 183.
    Liu GT, Glaser JS, Schatz NJ. High-dose methylprednisolone and acetazolamide for visual loss in pseudotumor cerebri. Am J Ophthalmol 1994;118(1):88–96.PubMedGoogle Scholar
  184. 184.
    Corbett JJ, Thompson HS. The rational management of idiopathic intracranial hypertension. Arch Neurol 1989;46(10):1049–1051.PubMedGoogle Scholar
  185. 185.
    Banta JT, Farris BK. Pseudotumor cerebri and optic nerve sheath decompression. Ophthalmology 2000;107(10):1907–1912.PubMedCrossRefGoogle Scholar
  186. 186.
    Kelman SE, Heaps R, Wolf A, Elman MJ. Optic nerve decompression surgery improves visual function in patients with pseudotumor cerebri. Neurosurgery 1992;30(3):391–395.PubMedCrossRefGoogle Scholar
  187. 187.
    Sergott RC. Optic nerve sheath decompression: neuropathologic, clinical, and hemodynamic results and rationale. Trans Am Ophthalmol Soc 1991;89:675–720.PubMedGoogle Scholar
  188. 188.
    Spoor TC, Ramocki JM, Madion MP, Wilkinson MJ. Treatment of pseudotumor cerebri by primary and secondary optic nerve sheath decompression. Am J Ophthalmol 1991;112(2): 177–185.PubMedGoogle Scholar
  189. 189.
    Keltner JL. Optic nerve sheath decompression. How does it work? Has its time come? Arch Ophthalmol 1988;106(10):1365–1369.PubMedGoogle Scholar
  190. 190.
    Hamed LM, Tse DT, Glaser JS, Byrne SF, Schatz NJ. Neuroimaging of the optic nerve after fenestration for management of pseudotumor cerebri. Arch Ophthalmol 1992;110(5):636–639.PubMedGoogle Scholar
  191. 191.
    Friedman DI. Pseudotumor cerebri. Neurol Clin 2004;22(1):99–131, vi.PubMedCrossRefGoogle Scholar
  192. 192.
    Rosenberg ML, Corbett JJ, Smith C, et al. Cerebrospinal fluid diversion procedures in pseudotumor cerebri. Neurology 1993;43(6):1071–1072.PubMedGoogle Scholar
  193. 193.
    Plotnik JL, Kosmorsky GS. Operative complications of optic nerve sheath decompression. Ophthalmology 1993;100(5):683–690.PubMedGoogle Scholar
  194. 194.
    Tse DT, Nerad JA, Anderson RL, Corbett JJ. Optic nerve sheath fenestration in pseudotumor cerebri. A lateral orbitotomy approach. Arch Ophthalmol 1988;106(10):1458–1462.PubMedGoogle Scholar
  195. 195.
    Binder DK, Horton JC, Lawton MT, McDermott MW. Idiopathic intracranial hypertension. Neurosurgery 2004;54(3):538–551; discussion 551-2.PubMedCrossRefGoogle Scholar
  196. 196.
    Johnston I, Paterson A, Besser M. The treatment of benign intracranial hypertension: A review of 134 cases. Surg Neurol 1981;16: 218–224.CrossRefGoogle Scholar
  197. 197.
    Johnston I, Besser M, Morgan MK. Cerebrospinal fluid diversion in the treatment of benign intracranial hypertension. J Neurosurg 1988; 69(2):195–202.PubMedGoogle Scholar
  198. 198.
    Eggenberger ER, Miller NR, Vitale S. Lumboperitoneal shunt for the treatment of pseudotumor cerebri. Neurology 1996;46(6): 1524–1530.PubMedGoogle Scholar
  199. 199.
    Burgett RA, Purvin VA, Kawasaki A. Lumboperitoneal shunting for pseudotumor cerebri. Neurology 1997;49(3):734–739.PubMedGoogle Scholar
  200. 200.
    Herzau V, Baykal HE. Long-term outcome of optic nerve sheath fenestration in pseudotumor cerebri. Klin Monatsbl Augenheilkd 1998; 213(3):154–160.PubMedGoogle Scholar
  201. 201.
    Horton JC, Seiff SR, Pitts LH, Weinstein PR, Rosenblum ML, Hoyt WF. Decompression of the optic nerve sheath for vision-threatening papilledema caused by dural sinus occlusion. Neurosurgery 1992;31(2):203–211.PubMedCrossRefGoogle Scholar
  202. 202.
    Tulipan N, Lavin PJ, Copeland M. Stereotactic ventriculoperitoneal shunt for idiopathic intracranial hypertension: technical note. Neurosurgery 1998;43(1):175–176.PubMedCrossRefGoogle Scholar
  203. 203.
    Hart A, David K, Powell M. The treatment of ‘acquired tonsillar herniation’ in pseudotumour cerebri. Br J Neurosurg 2000;14(6):563–565.PubMedCrossRefGoogle Scholar
  204. 204.
    Seiff SR, Shah L. A model for the mechanism of optic nerve sheath fenestration. Arch Ophthalmol 1990;108(9):1326–1329.PubMedGoogle Scholar
  205. 205.
    Higgins JN, Cousins C, Owler BK, Sarkies N, Pickard JD. Idiopathic intracranial hypertension: 12 cases treated by venous sinus stenting. J Neurol Neurosurg Psychiatry 2003;74(12): 1662–1666.PubMedCrossRefGoogle Scholar
  206. 206.
    Ogungbo B, Roy D, Gholkar A, Mendelow AD. Endovascular stenting of the transverse sinus in a patient presenting with benign intracranial hypertension. Br J Neurosurg 2003;17(6): 565–568.PubMedCrossRefGoogle Scholar
  207. 207.
    Karahalios DG, Rekate HL, Khayata MH, Apostolides PJ. Elevated intracranial venous pressure as a universal mechanism in pseudotumor cerebri of varying etiologies. Neurology 1996;46(1):198–202.PubMedGoogle Scholar
  208. 208.
    Cinciripini GS, Donahue S, Borchert MS. Idiopathic intracranial hypertension in prepubertal pediatric patients: characteristics, treatment, and outcome. Am J Ophthalmol 1999;127(2): 178–182.PubMedCrossRefGoogle Scholar
  209. 209.
    Huna-Baron R, Kupersmith MJ. Idiopathic intracranial hypertension in pregnancy. J Neurol 2002;249(8):1078–1081.PubMedCrossRefGoogle Scholar
  210. 210.
    Shapiro S, Yee R, Brown H. Surgical management of pseudotumor cerebri in pregnancy: case report. Neurosurgery 1995;37(4):829–831.PubMedCrossRefGoogle Scholar
  211. 211.
    McDonnell GV, Patterson VH, McKinstry S. Cerebral venous thrombosis occurring during an ectopic pregnancy and complicated by intracranial hypertension. Br J Clin Pract 1997; 51(3):194–197.PubMedGoogle Scholar
  212. 212.
    Gordon K. Pediatric pseudotumor cerebri: descriptive epidemiology. Can J Neurol Sci 1997;24(3):219–221.PubMedGoogle Scholar
  213. 213.
    Scott IU, Siatkowski RM, Eneyni M, Brodsky MC, Lam BL. Idiopathic intracranial hypertension in children and adolescents. Am J Ophthalmol 1997;124(2):253–255.PubMedGoogle Scholar
  214. 214.
    Lessell S. Pediatric pseudotumor cerebri (idiopathic intracranial hypertension). Surv Ophthalmol 1992;37(3):155–166.PubMedCrossRefGoogle Scholar
  215. 215.
    Dhiravibulya K, Ouvrier R, Johnston I, Procopis P, Antony J. Benign intracranial hypertension in childhood: a review of 23 patients. J Paediatr Child Health 1991;27(5):304–307.PubMedCrossRefGoogle Scholar
  216. 216.
    Phillips PH, Repka MX, Lambert SR. Pseudotumor cerebri in children. J AAPOS 1998; 2(1):33–38.PubMedGoogle Scholar
  217. 217.
    Speer C, Pearlman J, Phillips PH, Cooney M, Repka MX. Fourth cranial nerve palsy in pediatric patients with pseudotumor cerebri. Am J Ophthalmol 1999;127(2):236–237.PubMedCrossRefGoogle Scholar
  218. 218.
    Baker RS, Baumann RJ, Buncic JR. Idiopathic intracrania hypertension (pseudotumor cerebri) in pediatric patients. Pediatr Neurol 1989;5(1): 5–11.PubMedCrossRefGoogle Scholar
  219. 219.
    Weig SG. Asymptomatic idiopathic intracranial hypertension in young children. J Child Neurol 2002;17(3):239–241.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2007

Authors and Affiliations

  • Jane W. Chan
    • 1
  1. 1.Ophthalmology and NeurologyUniversity of Kentucky College of MedicineLexingtonUSA

Personalised recommendations